AZD9291,
AZD-9291,
osimertinib,
1421373-65-0,
AZD9291,
Mereletinib,
AZD 9291,
Tagrisso,
UNII-3C06JJ0Z2O,
3C06JJ0Z2O,
N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide,
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,
AK170511,
N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide,
N-(2-{[2-(Dimethylamino)ethyl](Methyl)amino}-4-Methoxy-5-{[4-(1-Methyl-1h-Indol-3-Yl)pyrimidin-2-Yl]amino}phenyl)prop-2-Enamide,
Mereletinib [INN],
Osimertinib [USAN],
osimertinibum,
N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide,
Tube720,
Osimertinib (AZD9291),
mereletinib (obsolete INN),
GTPL7719,
CHEMBL3353410,
SCHEMBL14660911,
CHEBI:90943,
AOB6268,
EX-A314,
DUYJMQONPNNFPI-UHFFFAOYSA-N,
C28H33N7O2,
HMS3653E10,
BCP08626,
KS-000007ZW,
ABP001123,
BDBM50029668,
MFCD27988062,
s7297,
ZINC98023177,
AKOS025290756,
CS-2018,
DB09330,
SB22952,
NCGC00378622-10,
2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-,
4CA-0243,
AC-29019,
AS-16943,
HY-15772,
QC-11454,
SC-94470,
FT-0696828,
SW219863-1,
X3507,
Mereletinib pound AZD-9291 Osimertinib pound(c),
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)acrylamide,
N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide,
N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide,
osimertinib mesilate,
Osimertinib mesylate,
AZD9291 mesylate,
D0RT2C,
Tyrosine Kinase Inhibitor - Ns,
C28-H33-N7-O2,
ACN-031533,
B1104,
A13681,
Osimertinib, 98%, a potent and selective mutated forms EGFR inhibitor - 25MG 25mg,
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-,
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide.,